Advent Srl Manufactures 13,000 Doses of Novel Covid-19 Vax
The first 4,000 doses have been delivered for use in the Phase II/III clinical trial COV002 by the University of Oxford.
Phase III Trial to Study Combination of Genentech’s Actemra, Gilead’s Remdesivir vs. Severe COVID-19
REMDACTA is expected to start enrolling patients in June, with researchers estimating they will recruit approximately 450 patients…
FDA greenlights ICU AI for predicting fatal COVID-19 complications
FDA greenlights ICU AI for predicting fatal COVID-19 complications…
PureTech advances experimental COVID-19 drug into global trials
LYT-100 employs a multimodal mechanism of action to potentially reduce, delay or prevent the lung dysfunction documented in COVID-19 patients
Roche Initiates Phase III Trial in COVID-19 Pneumonia
To evaluate Actemra/RoActemra plus remdesivir in hospitalized patients with severe Pneumonia.
Pregnancy May Reduce Cancer Risk through Epigenetic Reprogramming
Although pregnancy has been linked to a reduced risk of developing breast cancer, a full understanding of the mechanisms involved is still…
Bristol Myers jumps into synthetic lethality with $65M Repare deal
Bristol Myers jumps into synthetic lethality with $65M Repare deal…
Researchers develop AI tool able to predict cancer relapse
Researchers are hopeful that this 'ground-breaking approach' could accelerate the prediction of which patients are more at risk of their disease…